Fisher Asset Management, LLC
Position in CRNX — Crinetics Pharmaceuticals, Inc.
CIK 850529
PLANO, TX
Position in CRNX
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$27,701,336
-$7,614,240 QoQ
Shares Held
762,702
+0.5% QoQ
Ownership
0.723%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
15 quarters on record
Voting authority
Sole 53.395821697071725.ToString("F0")%
Shared 0.ToString("F0")%
None 46.604178302928275.ToString("F0")%
Common Shares in CRNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Fisher Asset Management, LLC holds $672,291,921 across 48 Biotechnology names. CRNX ranks #10 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
1,113,568 | $69,820,713 | |
| 2 | CYTK |
Cytokinetics Inc
|
768,264 | $50,636,280 | |
| 3 | RCUS |
Arcus Biosciences, Inc.
|
2,190,404 | $47,312,726 | |
| 4 | DNLI |
Denali Therapeutics Inc.
|
2,436,895 | $46,788,384 | |
| 5 | VRDN |
Viridian Therapeutics, Inc.DE
|
1,768,295 | $34,587,850 | |
| 6 | CLDX |
Celldex Therapeutics, Inc.
|
1,013,648 | $32,152,914 | |
| 7 | CGON |
CG Oncology, Inc.
|
465,033 | $31,473,433 | |
| 8 | IDYA |
IDEAYA Biosciences, Inc.
|
882,699 | $29,411,530 |
All Filings in CRNX
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $27,701,336 | 762,702 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $35,315,576 | 758,659 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $31,585,569 | 758,357 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $21,198,535 | 737,084 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $25,938,058 | 773,347 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $28,596,344 | 559,287 | Shares | Defined | 2025-02-05 | |
| 2024-09-30 | $24,635,258 | 482,099 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $19,916,769 | 444,670 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $20,410,236 | 436,023 | Shares | Defined | 2024-05-09 | |
| 2023-12-31 | $15,701,276 | 441,295 | Shares | Defined | 2024-03-05 | |
| 2023-09-30 | $1,601,796 | 53,860 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,230,243 | 68,271 | Shares | Sole | 2023-12-12 | |
| 2023-03-31 | $1,096,432 | 68,271 | Shares | Sole | 2023-12-12 | |
| 2022-12-31 | $1,407,709 | 76,924 | Shares | Defined | 2023-02-03 | |
| 2022-09-30 | $1,047,911 | 53,356 | Shares | Defined | 2022-11-08 | |
| No filing history on record for this holder in this stock. | ||||||